Next Article in Journal
Accumulation of Astaxanthin by a New Haematococcus pluvialis Strain BM1 from the White Sea Coastal Rocks (Russia)
Next Article in Special Issue
Rumphellaoic Acid A, a Novel Sesquiterpenoid from the Formosan Gorgonian Coral Rumphella antipathies
Previous Article in Journal
Effects of Estrogens and Estrogenic Disrupting Compounds on Fish Mineralized Tissues
Previous Article in Special Issue
Scopararanes C–G: New Oxygenated Pimarane Diterpenes from the Marine Sediment-Derived Fungus Eutypella scoparia FS26
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Oxygenated Eremophilane- and Neolemnane-Derived Sesquiterpenoids from the Soft Coral Lemnalia philippinensis

1
Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung 804, Taiwan
2
Graduate Institute of Marine Biotechnology and Department of Life Science and Institute of Biotechnology, National Dong Hwa University, Pingtung 944, Taiwan
3
National Museum of Marine Biology and Aquarium, Pingtung 944, Taiwan
4
Department of Biotechnology, Kaohsiung Medical University, Kaohsiung 807, Taiwan
5
Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 404, Taiwan
6
Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung 807, Taiwan
*
Author to whom correspondence should be addressed.
Mar. Drugs 2014, 12(8), 4495-4503; https://doi.org/10.3390/md12084495
Submission received: 8 April 2014 / Revised: 29 July 2014 / Accepted: 31 July 2014 / Published: 15 August 2014
(This article belongs to the Special Issue Terpenoids of Marine Origin)

Abstract

:
Five sesquiterpene-related metabolites (15), including two new eremophilane-type compounds, philippinlins C and D (1 and 2) and a 4,5-seconeolemnane philippinlin E (3), were isolated from the organic extract of a Taiwanese soft coral Lemnalia philippinensis. The structures of the new metabolites were determined on the basis of extensive spectroscopic analysis and by comparison of NMR data with those of related metabolites. Compound 3 was suggested to be derived from the neolemnane skeleton.

1. Introduction

In recent years, soft corals have become one of the most prolific sources for the discovery of novel secondary metabolites [1,2]. A variety of sesquiterpenes related to eremophilane- and neolemnane-types, and others have been reported from the Taiwanese soft corals of the genera Lemnalia and Paralemnalia [3,4,5,6,7,8,9,10]. Our recent study of the chemical constituents of the Lanyu soft coral L. philippinensis has yielded ylangene-type sesquiterpenoids, philippinlins A and B [11]. Our continuing investigation of the same collection of this organism again led to the isolation of two new eremophilane-type and one new neolemnane-derived sesquiterpenoids, philippinlins C–E (13), along with two known compounds, 11,12-dihydroxy-6,10-eremophiladiene (4) and 4-acetoxy-10-hydroxy-5-oxo-2,8-neolemnadiene (5) (Chart 1). The structures of 15 were elucidated on the basis of extensive spectroscopic analyses and by comparison of the spectral data with those of the related metabolites. The cytotoxicity of metabolites 15 towards human liver carcinoma (HepG2), human breast carcinoma (MDA-MB231) and human lung adenocarcinoma epithelial cells (A549) was evaluated; however, none of these compounds was shown to exhibit cytotoxicity towards these cancer cell lines in the present study.
Chart 1. Structures of metabolites 15.
Chart 1. Structures of metabolites 15.
Marinedrugs 12 04495 g004

2. Results and Discussion

Freshly collected soft coral was immediately cooled to −20 °C and kept frozen until extraction. The animal material was extracted exhaustively with EtOAc. The EtOAc extract was fractionated by silica gel column chromatography and the eluted fractions were further separated utilizing normal phase HPLC to afford three new sesquiterpenes (13) together with two known related sesquiterpenes (4 and 5). The known sesquiterpenes were readily identified as 11,12-dihydroxy-6,10-eremophiladiene (4) [4,5,12] and 4-acetoxy-10-hydroxy-5-oxo-2,8-neolemnadiene (5) [4,5], by comparison of their spectral data with those reported in the literatures.
Philippinlin C (1) was obtained as a colorless oil. Its molecular formula was determined as C15H22O3 on the basis of HR-ESI-MS (m/z 273.1465, [M + Na]+), indicating five degrees of unsaturation. IR absorptions was observed at 3420 cm−1, suggesting the presence of hydroxy group in 1. The 13C NMR and DEPT spectroscopic data (Table 1) of 1 revealed the presence of three methyls, four sp3 methylenes (including one oxygenated resonating at δC 68.3), one sp3 methine, two sp2 methines and five quaternary carbons (including one oxygenated carbons at δ 74.9, two olefinic carbons with resonances at δ 139.4 and 170.1 and one carbonyl carbon δ 199.1). From the required five degrees of unsaturation and the three double bonds known from the above data, a bicyclic sesquiterpene framework of 1 was deduced. The 1H NMR data revealed the presence of two olefinic methine protons as one singlet at δ 5.83 and one doublet at δ 5.89, respectively. Furthermore, one oxygenated methylene group (δ 3.62, d, J = 11 Hz; δ 3.44, d, J = 11.0 Hz) was also designated from the 1H NMR signals. The planar structure and all of the 1H and 13C chemical shifts of 1 were elucidated by 2D NMR spectroscopic analysis, in particular COSY and HMBC experiments (Figure 1). The COSY correlations of H-4 with both H2-3 and H3-15, and H2-8 with H2-9 allowed the establishment of two partial structures. The following key HMBC correlations permitted connection of the carbon skeleton: H-1 to C-3 and C-5; H-3 to C-2; H-6 to C-5, C-8, C-10 and C-11; H2-9 to C-1, C-5, C-7 and C-10; H2-12 to H-7; H3-13 to C-7, C-11 and C-12; H3-14 to C-4, C-5 and C-6 and H3-15 to C-3, C-4 and C-5. Thus, 1 was found to possess two hydroxy groups at C-11 and C-12, two double bonds at C-1/C-10 and C-6/C-7, three methyls at C-4, C-5 and C-11, and a ketone group at C-2. Furthermore, by comparison of the NMR data of 1 with those of 4, it was found that the 1H and 13C NMR data of 1 are similar to those of 4, except the replacement of the CH2 in 4 by a ketone group (C=O) in 1. The relative configurations of the two chiral centers at C-4 and C-5 in 1 were elucidated by the following NOE analysis. It was found that H3-14 showed NOE interactions with H3-15. Thus, assuming the β-orientation of H3-14, H3-15 should also be positioned on the β face. Based on the above results, the structure of 1 was mostly established. However, the relative configuration of a stereogenic center at C-11 can not be assigned at present stage.
The HR-ESI-MS spectrum of philippinlin D (2) exhibited a molecular ion peak at m/z 275.1622 ([M + Na]+), consistent with the molecular formula C15H24O3. Comparison of the NMR data (Table 1) of 2 with that of 1 revealed that the structures of both compounds are similar, with the difference that the ketocarbonyl carbon (C-2) of 1 was replaced by a hydroxy group-bearing methine carbon of 2. Thus, in the 13C NMR spectrum of 1 the signal at δc 199.1 was replaced by a signal at δc 64.1, and in the 1H NMR spectrum of 2 the signal at δH 4.10 (brs) could be attributed to a hydroxyl-bearing methine at C-2. The α-orientation of 2-hydroxy group was determined by comparison of the J1,2 of 2 with those of elongatols A–B [13], aromatin D and its 2-epimer [14]. Therefore, metabolite 2 was identified as the α-hydroxy derivative at C-2 of the known compound 4. Still, we are unable to determine the relative configuration of the chiral center C-11 at this time.
Table 1. 13C and 1H NMR spectral data for compounds 1, 2 and 3.
Table 1. 13C and 1H NMR spectral data for compounds 1, 2 and 3.
123
PositionδCδHδCδHδCδH
MultiplicityJ in HzMultiplicityJ in HzMultiplicityJ in Hz
1124.2 (CH)5.83 s121.4 (CH)5.54 d (4.0)124.6 (CH)5.69 d (10.0)
2199.1 (C) 64.1 (CH)4.10 br s132.0 (CH)5.97 d (10.0, 4.0)
342.6 (CH2)2.34 m36.6 (CH2)1.73 m; 1.65 m31.0 (CH2)2.08 dt (19.0, 4.0)
1.80 dd (19.0, 11.5)
438.3 (CH)2.05 m32.1 (CH)1.71 m34.2 (CH)2.16 m
539.9 (C) 38.6 (C) 40.4 (C)
6127.5 (CH)129.1 (CH)5.88 s148.3 (CH)6.30 s
7139.4 (C) 138.3 (C) 126.0 (C)
826.5 (CH2)2.35 m; 2.12 m27.5 (CH2)2.22 m; 2.02 m164.6 (C)
930.7 (CH2)2.57 ddd (13.0, 6.5, 1.5)29.7 (CH2)2.40 m;177.1 (C)
2.44 ddd (13.0, 5.0, 1.5)2.20 m
10170.1 (C) 147.7 (C) 27.7 (CH2)2.60 m; 2.54 m
1174.9 (C) 75.0 (C) 28.9 (CH2)2.45 m; 1.73 m
1268.3 (CH2)3.62 d (11.0);68.4 (CH2)3.60 d (11.0);83.4 (C)
3.44 d (11.0)3.40 d (11.0)
1323.8 (CH3)1.31 s23.7 (CH3)1.28 s16.8 (CH3)1.93 s
1419.4 (CH3)1.15 s19.4 (CH3)0.94 s13.7 (CH3)0.95 s
1515.2 (CH3)1.06 d (6.5)15.3 (CH3)0.99 d (6.0)15.1 (CH3)0.92 d (6.5)
Spectra recorded at 125 MHz in CDCl3 for 13C NMR and 500 MHz in CDCl3 for 1H NMR.
Figure 1. Selected COSY (▬) and HMBC (→) correlations of 1 and 3.
Figure 1. Selected COSY (▬) and HMBC (→) correlations of 1 and 3.
Marinedrugs 12 04495 g001
Philippinlin E (3) was obtained as a white powder. The molecular formula was determined to be C15H20O4, as deduced from its HR-ESI-MS (m/z 287.1257, [M + Na]+) and 13C NMR data (Table 1). A broad IR absorption at 3402 cm−1 indicated the presence of a hydroxy group. The NMR data (Table 1) showed resonances for one trisubstituted double bond (δH 6.30, s; δC 148.3 (CH), 126.0 (C)), one 1,1-disubstituted double bond (δH 5.97 (dd, J = 10.0, 4.0 Hz) and δH 5.69 (d, J = 10.0 Hz); δC 124.6 (CH) and δC 132.0 (CH)) and two carbonyl carbons (δC 177.1 and δC 164.6). To satisfy the six degrees of unsaturation and take into account the presence of two olefinic double bonds and two carbonyl groups, it was assumed that 3 possesses a bicyclic structure. From the COSY spectrum (Figure 1), the partial structures of a proton spin system extending from H-1 to H3-15 through H-4 and from H2-10 to H2-11 could be established, assigning a secondary methyl group at C-4. The molecular framework of 3 was further established by correlations of an HMBC experiment (Figure 1). The two rings and their connectivities to other substituents were elucidated on the basis of the following key HMBC correlations: H3-15 to C-3, C-4 and C-5; H3-14 to C-4, C-5, C-6 and C-12; H3-13 to C-6, C-7 and C-8; H2-11 to C-1, C-5, C-9 and C-12; H-1 to C-5 and C-12; H-4 to C-5 and C-12; H-6 to C-5, C-8 and C-12 and H-10 to C-12. Thus, this compound was found to possess two double bonds at C-1/C-2 and C-6/C-7, and two carboxyl groups at C-8 and C-9. Connection of all the above functional groups could lead to the planar structure 3 or an isomeric form 6 (Chart 2). For form 6, an α,β-unsaturated carboxylic acid and a γ-lacton ring should show IR absorptions at about 1690–1710 and 1760–1770 cm1, respectively. However, compound 3 exhibited carbonyl absorption at 1714 cm−1 only. Furthermore, 3 was found to have very similar NMR and IR spectroscopic data for the α,β-unsaturated ester moiety in comparison with those of 7 (Chart 2), which has been prepared previously by a stereospecific synthesis [15]. The relative stereochemistry was also confirmed by analysis of the NOESY spectrum (Figure 2). H3-14 showed NOE with both H2-11 and H3-15 but not with H-4. Thus, assuming a β-orientation of H3-14, both H2-11 and H3-15 should be placed on the β face. On the basis of above analysis, the structure of 3 was established.
Chart 2. Planar structure of Formula 6 and structure of 7.
Chart 2. Planar structure of Formula 6 and structure of 7.
Marinedrugs 12 04495 g005
Figure 2. Key NOESY correlations for 3.
Figure 2. Key NOESY correlations for 3.
Marinedrugs 12 04495 g002
The skeleton of 3 is new as a natural product, however, 3 has been found previously by treatment of a neolemnane-type compound, 4(S*)-acetoxy,10(S*)-hydroxy,5-oxo,1(S*),12(S*)neolemna-2(Z),8-diene, with a methanolic Na2CO3 solution in air to give an intermediate which should be the unpurified 3. This unpurified acid was further reacted with diazomethane to give the methyl ester of acid 3 [4]. We are the first group to isolate and characterize 3 from natural sources. Compound 3 might be a natural product, or an artifact from the oxidation of a related neolemane precursor.
A plausible biosynthetic pathway of 3 was postulated as shown in Scheme 1. This pathway involves oxidation with ring cleavage of a neolemnane precursor and the subsequent nucleophilic conjugate substitution to afford 3. The cytotoxicity of metabolites 15 against the growth of HepG2, MDA-MB231 and A549 carcinoma cells was studied. The results showed that 15 are not cytotoxic (IC50 > 20 μg/mL) toward the above cancer cells. We suggest that further investigation of other bioactivities of these metabolites should be carried out in the future.
Scheme 1. Proposed biosynthetic pathway for 3.
Scheme 1. Proposed biosynthetic pathway for 3.
Marinedrugs 12 04495 g003

3. Experimental Section

3.1. General Experimental Procedures

Optical rotation values were measured with a Jasco-P1010 digital polarimeter. Infrared spectra were obtained on a Varian Diglab FTS 1000 FT-IR spectrophotometer. NMR spectra were recorded on a Varian Unity INOVA 500 FT-NMR at 500 MHz for 1H and 125 MHz for 13C or on a Varian 400 MR FT-NMR at 400 MHz for 1H and 100 MHz for 13C in CDCl3 at 25 °C. ESIMS and HRESIMS data were recorded on a Bruker APEX II mass spectrometer. Column chromatography was performed on silica gel (230–400 mesh, Merck, Darmstadt, Germany). TLC was carried out on precoated Kieselgel 60 F254 (0.25 mm, Merck, Darmstadt, Germany) and spots were visualized by spraying with 10% H2SO4 solution followed by heating. Normal phase HPLC (NP-HPLC) was performed using a system comprised of a Hitachi L-7110 pump, a Hitachi L-7455 photodiode array detector and a Rheodyne 7725 injection port. A normal phase column (Supelco Ascentis® Si Cat #:581515-U, 25 cm × 21.2 mm, 5 μm) was used for NP-HPLC. Reverse phase HPLC (RP-HPLC) was performed using a system comprised of a Hitachi L-7100 pump, a Hitachi L-2455 photodiode array detector and a Rheodyne 7725 injection port. A reverse phase column (Varian Polaris C18-A, 250 mm × 10 mm, 5 μm) was used for RP-HPLC.

3.2. Animal Material

L. philippinensis, taxonomically identified by Chang-Feng Dai of National Taiwan University, was collected by hand using scuba off the coast of Lanyu, Taiwan, in August 2008, at a depth of 10–15 m, and stored in a freezer until extraction. A voucher sample was deposited at the Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Taiwan.

3.3. Extraction and Isolation

Sliced bodies of the soft coral L. philippinensis (0.8 kg, wet wt) were exhaustively extracted with ethyl acetate (EtOAc). The EtOAc extract was evaporated to yield a residue (10.7 g) which was subjected to column chromatography on silica gel by stepwise elution with n-hexane-EtOAc mixture and EtOAc-MeOH mixture, to give 25 fractions. Fraction 17, eluting with n-hexane–EtOAc (2:1), was further separated by silica gel open column with gradient elution (n-hexane–EtOAc, 13:2) to yield 5 subfractions (17A–E). Subfraction 17E was separated by normal phase HPLC using n-hexane–EtOAc(2:3) as the mobile phase to afford 1 (1.1 mg), 2 (2.7 mg) and 4 (1.0 mg). Both fractions 18 and 19, eluting with n-hexane–EtOAc (1:1–1:2), were combined and further separated by column chromatography over silica gel with gradient elution (n-hexane–EtOAc, 7:2) to yield 8 subfractions (18A–H). Subfraction 18D was separated by normal phase HPLC (n-hexane–EtOAc, 7:2) to afford 5 (3.5 mg). Subfraction 18G was separated by normal phase HPLC with the elution of n-hexane–EtOAc (2:1) to afford 3 (1.9 mg).
Philippinlin C (1): colorless oil; [α]25D = −175 (c 0.1, CHCl3); IR (neat) νmax 3420, 2923, 1652 and 1456 cm−1; 1H and 13C NMR data, see Table 1; ESIMS m/z 273 [M + Na]+; HRESIMS m/z 273.1465 (calcd. for C15H22O3Na, 273.1467) (Supplementary Information, Figures S1 and S2).
Philippinlin D (2): colorless oil; [α]25D = −234 (c 0.1, CHCl3); IR (neat) νmax 3384, 2922, 2857 and 1373 cm−1; 1H and 13C NMR data, see Table 1; ESIMS m/z 275 [M + Na]+; HRESIMS m/z 275.1622 (calcd. for C15H24O3Na, 275.1623) (Supplementary Information, Figures S3 and S4).
Philippinlin E (3): white powder; mp 124 °C; [α]25D = −134 (c 0.2, CHCl3); IR (neat) νmax 3402, 2940, 1714 and 1371 cm−1; 1H and 13C NMR data, see Table 1; ESIMS m/z 287 [M + Na]+; HRESIMS m/z 287.1257 (calcd. for C15H20O4Na, 287.1259) (Supplementary Information, Figures S5 and S6).

3.4. Cytotoxicity Testing

Cell lines were purchased from the American Type Culture Collection (ATCC). Cytotoxicity assays of compounds 15 were performed using the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide] colorimetric method [16,17].

4. Conclusions

Two new eremophilane-type compounds philippinlins C and D (1 and 2) a new 4,5-seconeolemnane philippinlin E (3), along with two known compounds, 11,12-dihydroxy-6,10-eremophilaiene (4) and 4-acetoxy-10-hydroxy-5-oxo-2,8-neolemnadiene (5), were discovered from the soft coral L. philippinensis. The molecular skeleton of 3 was discovered for the first time from natural sources.

Supplementary Files

Supplementary File 1

Acknowledgments

This research was supported by grants from the National Science Council (102-2628-B-110-002-MY2) and Aim for the Top University Program (02C030205) from Ministry of Education of Taiwan, awarded to Jyh-Horng Sheu.

Author Contributions

Jyh-Horng Sheu designed the whole experiment and contributed to manuscript preparation. Yun-Jie Xio and Yen-Ju Tseng carried out the experiment. Jui-Hsin Su and Bo-Wei Chen elucidated the molecular structures. Wangta Liu performed and analyzed the bioassay.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Wei, W.-C.; Sung, P.-J.; Duh, C.-Y.; Chen, B.-W.; Sheu, J.-H.; Yang, N.-S. Anti-Inflammatory activities of natural products isolated from soft corals of Taiwan between 2008 and 2012. Mar. Drugs 2013, 11, 4083–4126. [Google Scholar] [CrossRef]
  2. Blunt, J.W.; Copp, B.R.; Keyzers, R.A.; Munro, M.H.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2013, 30, 237–323. [Google Scholar] [CrossRef]
  3. Duh, C.-Y.; El-Gamal, A.A.H.; Song, P.-Y.; Wang, S.-K.; Dai, C.-F. Steroids and sesquiterpenoids from the soft corals Dendronephthya gigantea and Lemnalia cervicorni. J. Nat. Prod. 2004, 67, 1650–1653. [Google Scholar] [CrossRef]
  4. Izac, R.R.; Fenical, W.; Tagle, B.; Clardy, J. Neolemnane and eremophilane sesquiterpenoids from the Pacific soft coral Lemnalia africana. Tetrahedron 1981, 37, 2569–2573. [Google Scholar] [CrossRef]
  5. Jurek, J.; Scheuer, P.J. Sesquiterpenoids and norsesquiterpenoids from the soft coral Lemnalia aficana. J. Nat. Prod. 1993, 56, 508–513. [Google Scholar] [CrossRef]
  6. El-Gamal, A.A.H.; Chiu, E.-P.; Li, C.-H.; Cheng, S.-Y.; Dai, C.-F.; Duh, C.-Y. Sesquiterpenoids and norsesquiterpenoids from the Formosan soft coral Lemnalia laevis. J. Nat. Prod. 2005, 68, 1749–1753. [Google Scholar]
  7. Huang, H.-C.; Chao, C.-H.; Liao, J.-H.; Chiang, M.Y.; Dai, C.-F.; Wu, Y.-C.; Sheu, J.-H. A Novel chlorinated norsesquiterpenoid and two related new metabolites from the soft coral Paralemnalia thyrsoides. Tetrahedron Lett. 2005, 46, 7711–7714. [Google Scholar] [CrossRef]
  8. Huang, H.-C.; Wen, Z.-H.; Chao, C.-H.; Ahmed, A.F.; Chiang, M.Y.; Kuo, Y.-H.; Hsu, C.-H.; Chen, S.-P.; Sheu, J.-H. Novel sesquiterpenoids from the Formosan soft coral Paralemnalia thyrsoides. Tetrahedron Lett. 2006, 47, 8751–8755. [Google Scholar] [CrossRef]
  9. Wang, G.-H.; Huang, H.-C.; Su, J.-H.; Wu, Y.-C.; Sheu, J.-H. Paralemnolins J–P, new sesquiterpenoids from the soft coral Paralemnalia thyrsoides. Chem. Pharm. Bull. 2010, 58, 30–33. [Google Scholar] [CrossRef]
  10. Su, J.-H.; Lu, Y.; Hung, W.-Y.; Huang, C.-Y.; Chiang, M.Y.; Sung, P.-J.; Kuo, Y.-H.; Sheu, J.-H. Sesquiterpenoids from the Formosan soft coral Lemnalia flava. Chem. Pharm. Bull. 2011, 59, 698–702. [Google Scholar] [CrossRef]
  11. Xio, Y.-J.; Su, J.-H.; Chen, B.-W.; Tseng, Y.-J.; Wu, Y.-C.; Sheu, J.-H. Oxygenated ylangene-derived sesquiterpenoids from the soft coral Lemnalia philippinensis. Mar. Drugs 2013, 11, 3735–3741. [Google Scholar] [CrossRef]
  12. Kikuchi, H.; Manda, T.; Kobayashi, K.; Yamada, Y.; Iguchi, K. Anti-Tumor activity of lemnalol isolated from the soft coral Lemnalia tenuis Verseveldt. Chem. Pharm. Bull. 1983, 31, 1086–1088. [Google Scholar] [CrossRef]
  13. Wang, S.-K.; Duh, C.-Y. Nardosinane sesquiterpenoids from the Formosan soft coral Nephthea elongate. Chem. Pharm. Bull. 2007, 55, 762–765. [Google Scholar] [CrossRef]
  14. Bowden, B.F.; Coll, J.C.; Mitchell, S.J.; Skelton, B.W.; White, A.H. Studies of Australian soft corals. XXII. The structures of two novel sesquiterpenes and a nor sesquiterpene form Lemnalia africana, confirmed by a single-crystal X-ray study. Aust. J. Chem. 1980, 33, 2737–2747. [Google Scholar]
  15. Chen, Y.-H.; McDonald, F.E. New chiral synthons for efficient introduction of bispropionates via stereospecific oxonia–Cope rearrangements. J. Am. Chem. Soc. 2006, 128, 4568–4569. [Google Scholar] [CrossRef]
  16. Alley, M.C.; Scudiero, D.A.; Monks, A.; Hursey, M.L.; Czerwinski, M.J.; Fine, D.L.; Abbott, B.J.; Mayo, J.G.; Shoemaker, R.H.; Boyd, M.R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 1988, 48, 589–601. [Google Scholar]
  17. Scudiero, D.A.; Shoemaker, R.H.; Paull, K.D.; Monks, A.; Tierney, S.; Nofziger, T.H.; Currens, M.J.; Seniff, D.; Boyd, M.R. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 1988, 48, 4827–4833. [Google Scholar]

Share and Cite

MDPI and ACS Style

Xio, Y.-J.; Su, J.-H.; Tseng, Y.-J.; Chen, B.-W.; Liu, W.; Sheu, J.-H. Oxygenated Eremophilane- and Neolemnane-Derived Sesquiterpenoids from the Soft Coral Lemnalia philippinensis. Mar. Drugs 2014, 12, 4495-4503. https://doi.org/10.3390/md12084495

AMA Style

Xio Y-J, Su J-H, Tseng Y-J, Chen B-W, Liu W, Sheu J-H. Oxygenated Eremophilane- and Neolemnane-Derived Sesquiterpenoids from the Soft Coral Lemnalia philippinensis. Marine Drugs. 2014; 12(8):4495-4503. https://doi.org/10.3390/md12084495

Chicago/Turabian Style

Xio, Yun-Jie, Jui-Hsin Su, Yen-Ju Tseng, Bo-Wei Chen, Wangta Liu, and Jyh-Horng Sheu. 2014. "Oxygenated Eremophilane- and Neolemnane-Derived Sesquiterpenoids from the Soft Coral Lemnalia philippinensis" Marine Drugs 12, no. 8: 4495-4503. https://doi.org/10.3390/md12084495

Article Metrics

Back to TopTop